Belly Fat That Will Not Come Off: The Insulin Explanation
You have eaten less. You have moved more. The weight around your middle has not changed. That is not a willpower failure, and it is not a mystery — it is what happens when insulin is chronically elevated, and it is measurable long before anyone calls it diabetes.
Insulin Is a Storage Hormone
Insulin’s textbook job is moving glucose out of the bloodstream. That undersells it considerably. Insulin is an anabolic growth and storage hormone. It influences fat storage, sodium retention, sympathetic nervous system tone, blood vessel behavior and inflammatory signaling.
When it is chronically elevated, all of those systems sit in a shifted state — and one of the things that shifted state does is keep fat in storage. Eating less while insulin is high asks the body to release fuel it is being actively signaled to hold on to. The instruction and the hormone are working against each other.
Visceral Fat Is Not a Storage Depot. It Is an Organ.
The most useful thing to understand about the fat around your middle is that it is not inert. It is active tissue that secretes signaling molecules into the bloodstream continuously, and a substantial proportion of those signals are inflammatory.
Fat cells and immune cells share an evolutionary lineage, and adipose tissue kept a great deal of immune signaling capability. It releases the classical inflammatory cytokines, along with leptin, which is structurally related to that same family and behaves like it.
This has a practical consequence. C-reactive protein — the inflammation marker measured routinely — is produced by the liver largely under the direction of circulating IL-6, and a major source of that IL-6 is adipose tissue. When CRP is elevated in someone carrying central weight, a good deal of what is being measured is coming from the fat itself.
Why This Shows Up as Pain and Nerve Symptoms
Chronically elevated insulin and inflammatory signaling from visceral fat do not stay in one place. They affect the small blood vessels that feed the smallest nerves, and they raise the background level of inflammation everywhere.
That is the reason a hormone most people associate only with diabetes turns up in a conversation about burning feet and aching joints. The connection is not a metaphor — see burning and numb feet.
What to Measure
The tests that show elevated insulin are inexpensive and widely available. They are simply not what a routine panel is built around:
- Fasting insulin drawn with fasting glucose
- Triglyceride-to-HDL ratio from a standard lipid panel
- Waist circumference, which tracks visceral fat better than weight or BMI does
- A1C, read as one input rather than the answer
Worth knowing: the American Diabetes Association states that A1C and glucose-tolerance testing “reflect different aspects of glucose metabolism” and will “identify groups with incomplete concordance,” and that compared with A1C, the two-hour tolerance value “diagnoses more people with prediabetes and diabetes”1. Research presented to the Endocrine Society found A1C missed almost 73% of people who met tolerance-test criteria for diabetes2. More on that at blood sugar and nerve damage.
Frequently Asked Questions
Why does eating less not work on belly fat?
Because the problem is often hormonal rather than arithmetic. When insulin is chronically elevated it signals the body to store rather than release fuel, so cutting calories fights the hormone instead of changing it. Measuring fasting insulin tells you whether that is what is happening. See what normal lab work misses.
Is belly fat really different from other fat?
Yes. Visceral fat — the fat around the organs, which drives waist circumference — is metabolically active and secretes inflammatory signals into the bloodstream in a way that fat under the skin does not to the same degree. That is why waist measurement carries information that body weight alone does not.
Can this be reversed?
Insulin resistance responds to intervention, and it is one of the more modifiable metabolic problems. What varies is by how much and how quickly, and that depends on how long it has been running. We will not promise you a number. We will tell you what your measurements show. Begin with the Nerve Damage Score if you also have nerve symptoms.
References
- American Diabetes Association. Standards of Care in Diabetes — 2025, Section 2: Diagnosis and Classification of Diabetes. Diabetes Care 48(Suppl. 1):S27.
- Research presented to the Endocrine Society comparing A1C with oral glucose tolerance testing found A1C missed almost 73% of people who met tolerance-test criteria for diabetes.
Find Out Where You Stand
Five questions, about two minutes, no account needed.
Prefer to just ask a question? Call or text (314) 886-5902, or email info@regenerve.com. We are glad to talk through what is going on — there is no obligation and no pressure to become a patient. If you would rather read first, our Neuropathy Resource Library is free and there is nothing to sign up for.